welcome to mirna therapeutics about us clinical trials  pipeline technology investor relations careers contact us about mirna   mirna is a biopharmaceutical company focused on micrornabased oncology therapeutics   learn more about us   clinical trials   mrx mirna’s first product candidate was the first microrna mimic to enter clinical testing latest news   may   synlogic and mirna therapeutics agree to merger   may   mirna therapeutics reports first quarter  financial results   view all news   contact    sitemap   mirna therapeutics inc all rights reserved about mirna about us overview management board of directors clinical trials  pipeline technology investor relations careers contact us home microrna replacement therapy about mirna therapeutics mirna is a biopharmaceutical company focused on development of a pipeline of micrornabased oncology therapeutics mirna’s lead product candidate mrx the first microrna mimic to enter clinical development in oncology was studied as a single agent in a multicenter phase  clinical trial which included patients with primary liver cancer other solid cancers and hematological malignancies lymphomas and leukemias mrx was designed to deliver a mimic of the naturally occurring microrna tumor suppressor mir which is underexpressed in a wide variety of cancers mrx entered clinical testing in  in september  mirna voluntarily halted enrollment and dosing in the clinical study following multiple immunerelated severe adverse events saes observed in patients dosed with mrx over the course of the trial mirna’s owned and inlicensed intellectual property portfolio includes at least  issued us patents and more than  pending us and foreign applications mirna therapeutics was founded in  and is located in austin texas contact    sitemap   mirna therapeutics inc all rights reserved mirna management about us overview management board of directors clinical trials  pipeline technology investor relations careers contact us home microrna replacement therapy management mirna has assembled an experienced management team with leaders in microrna and cancer research and all aspects of drug and business development paul lammers md msc president  chief executive officer dr paul lammers has served as a member of mirna’s board of directors and as president and chief executive officer since november  previously dr lammers was the president of repros therapeutics inc a biopharmaceutical company dr lammers has also served as the chief medical officer for emd serono inc a biopharmaceutical division of merck kgaa senior vice president of clinical and regulatory affairs at zonagen inc which later became repros therapeutics and organon international a pharmaceutical company spending eight years in the commercial and clinical operations in europe and the united states dr lammers received an msc and md from the catholic university radboud university in nijmegen the netherlands alan fuhrman chief financial officer alan fuhrman has served as our chief financial officer since september  mr fuhrman previously served as the chief financial officer of ambit biosciences corporation a biopharmaceutical company including through the company’s initial public offering in  and until its sale to daiichi sankyo for up to  million prior to this role mr fuhrman served as chief financial officer of naviscan inc a privately held medical imaging company and as chief financial officer of sonus pharmaceuticals inc a pharmaceutical company mr fuhrman is a member of the board of directors of loxo oncology inc earlier in mr fuhrman’s career he practiced as a cpa with coopers and lybrand mr fuhrman received a bs in both business administration and agricultural economics from montana state university contact    sitemap   mirna therapeutics inc all rights reserved mirna therapeutics pipeline about us clinical trials  pipeline development pipeline technology investor relations careers contact us home microrna replacement therapy product development pipeline micrornas are naturally occurring short ribonucleic acid or rna molecules or oligonucleotides that play a critical role in regulating key biological pathways our scientists and others at leading academic institutions identified numerous tumor suppressor micrornas that play key roles in preventing normal cells from becoming cancerous and facilitating proper cancer immunosurveillance each microrna mimic in our pipeline is designed to replicate the activity of a single tumor suppressor mirna and regulate the expression of key oncogenes across multiple oncogenic pathways which can prevent proliferation and induce apoptosis in cancer cells the potential capacity to simultaneously affect multiple pathways and processes that are critical to cancer cell viability may make mimics of tumor suppressor micrornas an important new class of anticancer agents we are pursuing or have been granted therapeutic use patent claims related to several tumor suppressor micrornas as well as composition of matter claims for multiple chemistries and structures that are or may be used in or are contemplated for use with our therapeutic microrna mimics the following chart lists the most advanced microrna mimics in our pipeline as well as their latest stage of research and development contact    sitemap   mirna therapeutics inc all rights reserved mirna therapeutics pipeline about us clinical trials  pipeline development pipeline technology investor relations careers contact us home microrna replacement therapy product development pipeline micrornas are naturally occurring short ribonucleic acid or rna molecules or oligonucleotides that play a critical role in regulating key biological pathways our scientists and others at leading academic institutions identified numerous tumor suppressor micrornas that play key roles in preventing normal cells from becoming cancerous and facilitating proper cancer immunosurveillance each microrna mimic in our pipeline is designed to replicate the activity of a single tumor suppressor mirna and regulate the expression of key oncogenes across multiple oncogenic pathways which can prevent proliferation and induce apoptosis in cancer cells the potential capacity to simultaneously affect multiple pathways and processes that are critical to cancer cell viability may make mimics of tumor suppressor micrornas an important new class of anticancer agents we are pursuing or have been granted therapeutic use patent claims related to several tumor suppressor micrornas as well as composition of matter claims for multiple chemistries and structures that are or may be used in or are contemplated for use with our therapeutic microrna mimics the following chart lists the most advanced microrna mimics in our pipeline as well as their latest stage of research and development contact    sitemap   mirna therapeutics inc all rights reserved mirna therapeutics inc  home mirna therapeutics home about us research pipeline  clinical trials news careers contact us discover mrx a mirnabased therapy  reduces tumor burden and extends survival in mice clinical testing is expected to begin in q  tumor suppressor micrornas kill cancer cells by regaining control over multiple oncogenic pathways which represents a new paradigm in cancer therapy read more about mirna therapeutics mirna therapeutics inc mirna is a biopharmaceutical company focused on micrornadirected oncology therapies mirna’s pipeline has broad therapeutic utility in solid and hematologic cancers and provides opportunities for partnering and licensing mirna filed its first ind in q  for its lead candidate mrx and is currently conducting a phase i clinical trial in patients with unresectable primary liver cancer or metastatic cancer with liver involvement based on the advanced stage of mirna’s mirna technology pipeline breadth and ip estate the company is wellpositioned to capitalize on the emerging field of mirna therapeutics and to have a positive impact on the future of cancer patient care about microrna micrornas mirnas are small noncoding rna molecules that occur naturally in human cells misregulation of these critical cellular components is a frequent event in the development of genetically manifested human disease mirna therapeutics is developing treatments that have the promise of being effective in humans by restoring normal mirna function read more  about mirna replacement therapy mirna replacement therapy is a new approach to treat human disease it involves the reintroduction of a synthetic version of a mirna that is depleted in the diseased tissue since the synthetic and the natural mirna are virtually indistinguishable mirnabased therapeutics have the potential of not exhibiting nonspecific side effects the synthetic mirna counteracts diseasedependent processes and induces a therapeutic response read more  mirna therapeutics announces interim phase  safety data on lead product candidate mrx at aacr annual meeting read more mirna therapeutics appoints casi deyoung as chief business office read more mirna therapeutics announces scientific publication that suggests enhanced potency of lead therapeutic microrna in combination with fda approved lung cancer drug read more press release  press release  press release  copyright   mirna therapeutics inc  an equal opportunity employer  all rights reserved contact us contact info mirna therapeutics inc  woodward st suite   austin tx   usa  fax for inquiries please use the following contacts general infomirnarxcom business development busdevmirnarxcom mirna therapeutics inc  product pipeline review    rnr market research advanced search     salesrnrmarketresearchcom search market research reports ﻿ market research assistance salesrnrmarketresearchcom on the web related markets anesthesia drugsbiosimilarbiopharmaceuticalsclinical trialdietary supplementsdietary supplementdiseases  treatmentcancer drugsdiabetes drugshypertension drugshiv related market reportsmirna therapeutics inc  product pipeline review   home  life sciences  pharmaceuticals  biopharmaceuticals  report detail mirna therapeutics inc  product pipeline review   publisher name  global markets direct date feb no of pages  price single user license us  corporate user license us  report descriptiontable of contentnews  blogother reportsour offerings global markets directs mirna therapeutics inc  product pipeline review   provides an overview of the mirna therapeutics incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of mirna therapeutics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of mirna therapeutics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of mirna therapeutics incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the mirna therapeutics incs pipeline products reasons to buy evaluate mirna therapeutics incs strategic position with total access to detailed information on its product pipeline assess the growth potential of mirna therapeutics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the mirna therapeutics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of mirna therapeutics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of mirna therapeutics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of mirna therapeutics inc and identify potential opportunities in those areas avoid intellectual property rights related issues mirna therapeutics inc  product pipeline review   table of contents table of contents  list of tables  list of figures  mirna therapeutics inc snapshot  mirna therapeutics inc overview  key information  key facts  mirna therapeutics inc  research and development overview  key therapeutic areas  mirna therapeutics inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  pipeline products  combination treatment modalities  pipeline products  partnered products  partnered productscombination treatment modalities  mirna therapeutics inc  pipeline products glance  mirna therapeutics inc  clinical stage pipeline products  phase i productscombination treatment modalities  mirna therapeutics inc  early stage pipeline products  preclinical productscombination treatment modalities  discovery productscombination treatment modalities  mirna therapeutics inc  drug profiles  mrx  product description  mechanism of action  rd progress  let  mir  product description  mechanism of action  rd progress  mirrx  product description  mechanism of action  rd progress  mirrx  product description  mechanism of action  rd progress  mirrx  product description  mechanism of action  rd progress  mirrxlet  product description  mechanism of action  rd progress  mirna therapeutics inc  pipeline analysis  mirna therapeutics inc  pipeline products by target  mirna therapeutics inc  pipeline products by route of administration  mirna therapeutics inc  pipeline products by molecule type  mirna therapeutics inc  recent pipeline updates  mirna therapeutics inc  dormant projects  mirna therapeutics inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables mirna therapeutics inc key information  mirna therapeutics inc key facts  mirna therapeutics inc  pipeline by indication   mirna therapeutics inc  pipeline by stage of development   mirna therapeutics inc  monotherapy products in pipeline   mirna therapeutics inc  combination treatment modalities in pipeline   mirna therapeutics inc  partnered products in pipeline   mirna therapeutics inc  partnered products combination treatment modalities   mirna therapeutics inc  phase i   mirna therapeutics inc  preclinical   mirna therapeutics inc  discovery   mirna therapeutics inc  pipeline by target   mirna therapeutics inc  pipeline by route of administration   mirna therapeutics inc  pipeline by molecule type   mirna therapeutics inc  recent pipeline updates   mirna therapeutics inc  dormant developmental projects  list of figures mirna therapeutics inc  pipeline by top  indication   mirna therapeutics inc  pipeline by stage of development   mirna therapeutics inc  monotherapy products in pipeline   mirna therapeutics inc  partnered products in pipeline   mirna therapeutics inc  pipeline by top  target   mirna therapeutics inc  pipeline by top  route of administration   mirna therapeutics inc  pipeline by top  molecule type   renewable energy sources needs to boost global microgrids marketthe global market for microgrid was worth us billion in  and is anticipated to touch an estimate of us billion by  dealers in the market for microgrids are incessantly improving the network hostinghellipmanufacturing trends in the coming daysthe manufacturing industry may be encountering some breezes but it is irrefutably in the middle of a technological revival that is altering the appearance structures and practices of the modern factory notwithstanding the jeopardies andhelliptop  emerging technologiesthe world economic forum wef and scientific american lately unveiled the major technological innovation list of the top ten emerging technologies this list emphasizes on the technological developments which have the supremacy to transform industrieshellipglobal biosimilars market to be led by novartis by biologics which are typically inoculated or injected are formed in living entities making them more challenging and costly to manufacture than the usual pills contrived from chemicals observing that mockups are mostly identical to thehellipglobal thyroid gland disorder treatment market to grow steadilythe global thyroid gland disorder treatment market was worth us billion in  and is projected to reach a market value of us billion in  intensifying at a cagr of  from  to   thehellip highspeed data transmission and high volume needs propel fiber optic connectors market fiber optic connectors are a substantial fragment of the global telecommunication industry optical fibers are joined using fiber optic connectors which allow the light conduction between two consecutive optical fibers an additional im…extensive use of digital technologies for diagnostic applications to boost global optical imaging market the global optical imaging system market is predicted to reach us  billion by  it is expected to grow at a stable rate and will post a cagr of more than  in the coming years the growing market infiltration of digital …foremost trends in global pet care market the global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments it is estimated that the global pet care market will grow at a cagr o…china to review its food security laws china has arisen as the globe’s firmest developing economy in addition china brags about the biggest population pool in the world in recent times the one child policy in the republic was terminated this is anticipated to upsur…improving standards of living to boost global consumer durables market consumer durables is a cataloguing of consumer goods that are not essential to be bought very often as they are fashioned in a way so as to last for an extended period of time profits in the consumer durables sector were most profoundly… global and chinese biopharmaceuticals industry  market research report published jun        price us  onwards        pages  the global and chinese biopharmaceuticals industry  market research report is a professional and indepth study on the current state of the global biopharmaceuticals industry with a focus on the chinese market the report provides key statistics on the market status of the biopharmaceuticals manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industryfirstly the report provides a basic overview of the industry including i bio industry markets in china published may        price us  onwards        pages  chinas demand for bio industry has grown at a fast pace in the past decade in the next decade both production and demand will continue to grow the chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output imports  exports consumer consumption and capital investment for over two decades this new study examines chinas economic trends investment environment industry development supply and demand industry capacity industry biotechnology products companies in china published may        price us  onwards        pages  this study focuses on chinas biotechnology products industry assessments and company profiles in the two past decades the industry has been growing at a fast pace the dramatic expansions of the manufacturing capabilities and rising consumer consumptions in china have transformed chinas society and economy china is one of the worlds major producers for industrial and consumer products far outpacing other economies in the world china is the worlds fastest growing market for the consumpti biotechnology products industry industry forecasts  china focus published may        price us  onwards        pages  this study focuses on chinas biotechnology products industry forecasts in the two past decades the industry has been growing at a fast pace the dramatic expansions of the manufacturing capabilities and rising consumer consumptions in china have transformed chinas society and economy china is one of the worlds major producers for industrial and consumer products far outpacing other economies in the world china is the worlds fastest growing market for the consumptions of goods and servic emea europe middle east and africa biochar market report  published apr        price us  onwards        pages  in this report the emea biochar market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  geographically this report split emea into europe the middle east and africa with sales mt revenue million usd market share and growth rate of biochar for these regions from  to  forecast  europe germany france uk russia italy and benelux  middle east saudi  actelion partnering deals and alliances  to  published apr        price us  onwards        pages  delivery of this report will take  days after purchase this report provides all the information you require to better understand actelion and its partnering interests and activities since  the partnering deals and alliance since  report provides an indepth insight into the partnering activity of one of the worlds leading life sciences companies on demand company reports are prepared upon purchase to ensure inclusion of the most up to  alkermes partnering deals and alliances  to  published apr        price us  onwards        pages  delivery of this report will take  days after purchase this report provides all the information you require to better understand alkermes and its partnering interests and activities since  the partnering deals and alliance since  report provides an indepth insight into the partnering activity of one of the worlds leading life sciences companies on demand company reports are prepared upon purchase to ensure inclusion of the most up to  amylin pharmaceuticals partnering deals and alliances  to  published apr        price us  onwards        pages  delivery of this report will take  days after purchase this report provides all the information you require to better understand amylin pharmaceuticals and its partnering interests and activities since  the partnering deals and alliance since  report provides an indepth insight into the partnering activity of one of the worlds leading life sciences companies on demand company reports are prepared upon purchase to ensure inclusion of t astrazeneca partnering deals and alliances  to  published apr        price us  onwards        pages  delivery of this report will take  days after purchase this report provides all the information you require to better understand astrazeneca and its partnering interests and activities since  the partnering deals and alliance since  report provides an indepth insight into the partnering activity of one of the worlds leading life sciences companies on demand company reports are prepared upon purchase to ensure inclusion of the most up services value for money we believe in optimum utilization of available budget and resources while servicing our clients your market research requirements we keep the same approach in focus to help you get the best value for your s ever growing inventory ranging from the smallest feasible  required data datasheets data facts swot analysis company profiles etc to full research reports that help you make decisions our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than  niche sectors one stop solution need a custom research report on medical devices market require all available business intelligence on d printing industry exploring fb sector of a particular countryregion rnrmarketresearchcom is your onestopsolution to all market intelligence needs we not only offer custom research and consulting services we also bundle reports to meet your needs and help you fetch the data analysis you require for your business dedicated client engagement not limited to only finding relevant reports for you our client engagement team dedicates its efforts to understand your business need and accordingly maps available research data to help you move forward call your client engagement executive any time of your day and get your questions answered in order to make the correct business decision saving time and efforts simply share your research requirement details with us and let us do all the hard work to find required intelligence for you when you add up our one stop solution and dedicated client engagement services mentioned above you obviously know the time and effort saving you do by working with us payment flexibility working with fortune  organizations we understand the importance of being flexible for payments share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done postpurchase research support have questions after reading a report  datasheet bought through us not sure about the methodology used for data available in the research talk to us  share your questions with us and if required we will connect you with the analystsauthors of the reports and ensure you get satisfactory answers for the same need more data  analysis  reports on the topic of your researchproject the rnrmarketresearchcom team is here for you x to support you with your postpurchase requirements subscription offers  packages get in touch with us for more details  salesrnrmarketresearchcom       ad hoc pay  as  you  go  bucket subscriptions fixed cost for of reports customize  personalize as per your needs avail upto  discount on below publisher reports azoth analytics technavio biopharmaceuticals market research reports under pharmaceuticals at rnr market research advanced search     salesrnrmarketresearchcom search market research reports market research assistance salesrnrmarketresearchcomon the web refine resultby datelast monthlast  monthslast  monthslast yearlast  years by price  home     life sciences    pharmaceuticals    biopharmaceuticals biopharmaceuticals market research reports globally the biopharmaceuticals market is expected to drive the double digit growth rate the biopharma segment is more costly than traditional medications which needs higher investments and longer development times the biopharmaceuticals segment addreses several therapeutic areas such as neurology infectious diseases cardiovascular oncology etc biopharmaceuticals is categorised into the recombinant proteins insulin erythropoietins interferons colony stimulating factors immunoglobulins recombinant blood factors growth hormones recombinant enzymes interleukins growth factors monoclonal antibodies and purified proteins the recombinant proteins lead the biopharmaceuticals market globally with highest percentage follwed by monoclonal antibodies the recombinant proteins market is considered to be down in developed countries due to biosimilar entry restrictions into the market and increase in cost containment measures the monoclonal antibodies market witness strong gview more globally the biopharmaceuticals market is expected to drive the double digit growth rate the biopharma segment is more costly than traditional medications which needs higher investments and longer development times the biopharmaceuticals segment addreses several therapeutic areas such as neurology infectious diseases cardiovascular oncology etc biopharmaceuticals is categorised into the recombinant proteins insulin erythropoietins interferons colony stimulating factors immunoglobulins recombinant blood factors growth hormones recombinant enzymes interleukins growth factors monoclonal antibodies and purified proteins the recombinant proteins lead the biopharmaceuticals market globally with highest percentage follwed by monoclonal antibodies the recombinant proteins market is considered to be down in developed countries due to biosimilar entry restrictions into the market and increase in cost containment measures the monoclonal antibodies market witness strong growth in developed and emerging economies due to rich late stage pipeline products the global biopharmaceutical market covers top eight regions us germany japan france italy spain uk and canada also the share is increased in emerging markets such as brazil russia india china mexico turkey and south korea the biggest restraint for this market is to get market approval for its products out of every ten drugs only three to four succeed to obtain concerned market approval and ones got the approval turned to be goldmines for investorsthe us is the biggest geographic market witness sharp decline due to spate of policy changes grants and the recent health care reform bill and aarc the industry drives due to its effectiveness and its ability to defend outside the reach of traditional small molecule drugs growth of biopharma in emerging markets approval of new products expansion of therapeutic drugs from existing products increase in biopharmaceutical research activity and participating in merger and acquisition activities including involvement in bioventures the biopharmaceutical market is directing towards licensing deals and allainces to get benefit to enter into the newer technologies of biopharmaceutical segment view less biopharmaceuticals market research reports titlepublishedprice global and chinese biopharmaceuticals industry  market research reportby prof research icals manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industryfirstly the report provides a basic overview of the industry including its definition applications and manufacturing tecjun bio industry markets in chinaby amid er consumption and capital investment for over two decades this new study examines chinas economic trends investment environment industry development supply and demand industry capacity industry structure marketing channels and major industrymay biotechnology products companies in chinaby amid and economy china is one of the worlds major producers for industrial and consumer products far outpacing other economies in the world china is the worlds fastest growing market for the consumptions of goods and services the chinese economy mamay biotechnology products industry industry forecasts  china focusby amid one of the worlds major producers for industrial and consumer products far outpacing other economies in the world china is the worlds fastest growing market for the consumptions of goods and services the chinese economy maintains a high speed grmay emea europe middle east and africa biochar market report by qyresearch group enue million usd market share and growth rate of biochar for these regions from  to  forecast  europe germany france uk russia italy and benelux  middle east saudi arabia israel uae and iran  africa soapr actelion partnering deals and alliances  to by current partnering th insight into the partnering activity of one of the worlds leading life sciences companies on demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data the reapr alkermes partnering deals and alliances  to by current partnering th insight into the partnering activity of one of the worlds leading life sciences companies on demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data the reapr amylin pharmaceuticals partnering deals and alliances  to by current partnering ides an indepth insight into the partnering activity of one of the worlds leading life sciences companies on demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data apr astrazeneca partnering deals and alliances  to by current partnering depth insight into the partnering activity of one of the worlds leading life sciences companies on demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data thapr biocon partnering deals and alliances  to by current partnering h insight into the partnering activity of one of the worlds leading life sciences companies on demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data the repapr                 next » avail upto  discount on below publisher reports azoth analytics technavio mirna therapeutics inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies  pharma info market research report mirna therapeutics inc  product pipeline review   published by global markets direct product code  published february   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license mirna therapeutics inc  product pipeline review   published february   content info  pages description summary global markets directs mirna therapeutics inc  product pipeline review   provides an overview of the mirna therapeutics incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of mirna therapeutics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of mirna therapeutics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of mirna therapeutics incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the mirna therapeutics incs pipeline products reasons to buy evaluate mirna therapeutics incs strategic position with total access to detailed information on its product pipeline assess the growth potential of mirna therapeutics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the mirna therapeutics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of mirna therapeutics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of mirna therapeutics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of mirna therapeutics inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures mirna therapeutics inc snapshot mirna therapeutics inc overview key information key facts mirna therapeutics inc  research and development overview key therapeutic areas mirna therapeutics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  combination treatment modalities pipeline products  partnered products partnered productscombination treatment modalities mirna therapeutics inc  pipeline products glance mirna therapeutics inc  clinical stage pipeline products phase i productscombination treatment modalities mirna therapeutics inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities mirna therapeutics inc  drug profiles mrx product description mechanism of action rd progress let  mir product description mechanism of action rd progress mirrx product description mechanism of action rd progress mirrx product description mechanism of action rd progress mirrx product description mechanism of action rd progress mirrxlet product description mechanism of action rd progress mirna therapeutics inc  pipeline analysis mirna therapeutics inc  pipeline products by target mirna therapeutics inc  pipeline products by route of administration mirna therapeutics inc  pipeline products by molecule type mirna therapeutics inc  recent pipeline updates mirna therapeutics inc  dormant projects mirna therapeutics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables mirna therapeutics inc key information mirna therapeutics inc key facts mirna therapeutics inc  pipeline by indication  mirna therapeutics inc  pipeline by stage of development  mirna therapeutics inc  monotherapy products in pipeline  mirna therapeutics inc  combination treatment modalities in pipeline  mirna therapeutics inc  partnered products in pipeline  mirna therapeutics inc  partnered products combination treatment modalities  mirna therapeutics inc  phase i  mirna therapeutics inc  preclinical  mirna therapeutics inc  discovery  mirna therapeutics inc  pipeline by target  mirna therapeutics inc  pipeline by route of administration  mirna therapeutics inc  pipeline by molecule type  mirna therapeutics inc  recent pipeline updates  mirna therapeutics inc  dormant developmental projects list of figures mirna therapeutics inc  pipeline by top  indication  mirna therapeutics inc  pipeline by stage of development  mirna therapeutics inc  monotherapy products in pipeline  mirna therapeutics inc  partnered products in pipeline  mirna therapeutics inc  pipeline by top  target  mirna therapeutics inc  pipeline by top  route of administration  mirna therapeutics inc  pipeline by top  molecule type  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved mirna therapeutics inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports mirna therapeutics inc  product pipeline review   mirna therapeutics inc  product pipeline review   wgr  february  global  pages global markets direct description table of content sample report enquiry before buy related reports mirna therapeutics inc  product pipeline review  summaryglobal markets direct’s ‘mirna therapeutics inc  product pipeline review  ’ provides an overview of the mirna therapeutics inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of mirna therapeutics inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of mirna therapeutics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of mirna therapeutics inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the mirna therapeutics inc’s pipeline productsreasons to buy evaluate mirna therapeutics inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of mirna therapeutics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the mirna therapeutics inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of mirna therapeutics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of mirna therapeutics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of mirna therapeutics inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures mirna therapeutics inc snapshot mirna therapeutics inc overview key information key facts mirna therapeutics inc  research and development overview key therapeutic areas mirna therapeutics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  combination treatment modalities pipeline products  partnered products partnered productscombination treatment modalities mirna therapeutics inc  pipeline products glance mirna therapeutics inc  clinical stage pipeline products phase i productscombination treatment modalities mirna therapeutics inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities mirna therapeutics inc  drug profiles mrx product description mechanism of action rd progress let  mir product description mechanism of action rd progress mirrx product description mechanism of action rd progress mirrx product description mechanism of action rd progress mirrx product description mechanism of action rd progress mirrxlet product description mechanism of action rd progress mirna therapeutics inc  pipeline analysis mirna therapeutics inc  pipeline products by target mirna therapeutics inc  pipeline products by route of administration mirna therapeutics inc  pipeline products by molecule type mirna therapeutics inc  recent pipeline updates mirna therapeutics inc  dormant projects mirna therapeutics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesmirna therapeutics inc key information mirna therapeutics inc key facts mirna therapeutics inc  pipeline by indication  mirna therapeutics inc  pipeline by stage of development  mirna therapeutics inc  monotherapy products in pipeline  mirna therapeutics inc  combination treatment modalities in pipeline  mirna therapeutics inc  partnered products in pipeline  mirna therapeutics inc  partnered products combination treatment modalities  mirna therapeutics inc  phase i  mirna therapeutics inc  preclinical  mirna therapeutics inc  discovery  mirna therapeutics inc  pipeline by target  mirna therapeutics inc  pipeline by route of administration  mirna therapeutics inc  pipeline by molecule type  mirna therapeutics inc  recent pipeline updates  mirna therapeutics inc  dormant developmental projects list of figuresmirna therapeutics inc  pipeline by top  indication  mirna therapeutics inc  pipeline by stage of development  mirna therapeutics inc  monotherapy products in pipeline  mirna therapeutics inc  partnered products in pipeline  mirna therapeutics inc  pipeline by top  target  mirna therapeutics inc  pipeline by top  route of administration  mirna therapeutics inc  pipeline by top  molecule type   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send mirn stock price  mirna therapeutics inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers ba  t  amd  biib  akam  uhs  rhi  jnpr  latest newsall times eastern p facebook hits  billion users earnings beat live blog p updated stock market ends at record on robust earnings as fed issues policy update p updated trump puts his hands together for ‘the late great abraham lincoln’ p updated the nintendo switch’s sellout launch in many charts p updated year treasury yield falls the most in five weeks after fed statement p updated for transgender americans workplace discrimination isn’t limited to the military p updated your k match may have some strings attached p this is the worst mistake people make at work p why equalweighted stockmarket indexes bounce back faster from bear markets p nutrisystem shares rally on betterthanexpected earnings to be replaced home investing quotes stocks united states mirn overview compare quotes stock screener earnings calendar sectors nasdaq mirn us nasdaq join td ameritrade find a broker mirna therapeutics inc watchlist createmirnalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee na pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones mirna therapeutics downgraded to perform from outperform at oppenheimer sep   at  am et by tomi kilgore mima therapeutics downgraded to market perform from outperform at leerink partners aug   at  am et by tomi kilgore the daily startup market turbulence puts biotech ipos in question oct   at  am et on the wall street journal recent news other news press releases medicenna bolsters management team medicenna bolsters management team jul   at  am et on cnw group applied optoelectronics inc aaoi leads  notable investor filings applied optoelectronics inc aaoi leads  notable investor filings may   at  am et on investorplacecom air products  chemicals inc apd and united security bancshares usbo lead  investor filings air products  chemicals inc apd and united security bancshares usbo lead  investor filings may   at  am et on investorplacecom mirna therapeutics to merge with synlogic mirna therapeutics to merge with synlogic may   at  am et on seeking alpha premarket gainers as of  am premarket gainers as of  am may   at  am et on seeking alpha zackscom featured highlights mannkind mirna therapeutics nextera energy sabre and avinger dec   at  am et on zackscom profit from these  stocks with rising pe ratio dec   at  am et on zackscom zackscom featured highlights mannkind mirna therapeutics nextera energy one gas and avinger dec   at  am et on zackscom buy  stocks with rising pe to bust a common myth dec   at  am et on zackscom q mirna therapeutics inc nov   at  pm et on edgar online  edg  q k healthcare ratings roundup  upgradesdowngrades sep   at  am et on seeking alpha biggest movers in manufacturing stocks now – aks mdgl kin mrtx sep   at  pm et on investorplacecom exploring grahams netnet working capital strategy part  the first  months sep   at  pm et on seeking alpha healthcare ratings roundup  new coverage sep   at  am et on seeking alpha hottest manufacturing stocks now – epzm fit dmpi crbp sep   at  pm et on investorplacecom mirna therapeutics mirn is in oversold territory whats next sep   at  am et on zackscom hottest manufacturing stocks now – spu ccur mirn mtl aug   at  am et on investorplacecom biggest movers in manufacturing stocks now – yeco kura vtgn cnce aug   at  pm et on investorplacecom value screeners identify cheap company stocks aug   at  pm et on gurufocuscom hottest manufacturing stocks now – cycc mdvn yeco bnso aug   at  pm et on investorplacecom blog coverage mirna announced reverse merger agreement blog coverage mirna announced reverse merger agreement may   at  am et on accesswire synlogic and mirna therapeutics agree to merger synlogic and mirna therapeutics agree to merger may   at  am et on businesswire  bzx mirna therapeutics reports first quarter  financial results mirna therapeutics reports first quarter  financial results may   at  pm et on businesswire  bzx mirna therapeutics reports financial results for the fourth quarter and full year ended december   mar   at  pm et on businesswire  bzx mirna therapeutics reports third quarter  financial results and mrx clinical program updates nov   at  pm et on businesswire  bzx mirna therapeutics halts phase  clinical study of mrx sep   at  pm et on businesswire  bzx mirna therapeutics to participate in two healthcare investor conferences in september aug   at  am et on businesswire  bzx mirna therapeutics reports second quarter  financial results and program updates aug   at  am et on businesswire  bzx mirna therapeutics inc mirna therapeutics inc is a biopharmaceutical company which engages in the development of micrornabased oncology therapeutics its products includes mir mir mir mir and let the company was founded matthew m winkler in  and is headquartered in austin tx see full profile analyst ratings sell under hold over buy number of ratings  full ratings mirnas murky clinical strategy leaves hc wainwright hesitant sep   at  am et on benzingacom benzingas top downgrades sep   at  am et on benzingacom hc wainwright initiates mirna at buy sees  upside sep   at  pm et on benzingacom competitors name chg  market cap petmed express inc  m nexgenrx inc  m pharmerica corp  m omni health inc  m competitor data provided by partner content trending tickers powered by fb  gild  pypl  jdst  jnug  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience stocks index  markets index bulletin investor alert new york markets after hours market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pfacebook hits  billion users earnings beat live blog pstock market ends at record on robust earnings as fed issues policy update ptrump puts his hands together for ‘the late great abraham lincoln’ pthe nintendo switch’s sellout launch in many charts pyear treasury yield falls the most in five weeks after fed statement pfor transgender americans workplace discrimination isn’t limited to the military pyour k match may have some strings attached pthis is the worst mistake people make at work pwhy equalweighted stockmarket indexes bounce back faster from bear markets pnutrisystem shares rally on betterthanexpected earnings pbuffalo wild wings drop  on high chicken wing costs pbreakingf networks shares fall after weak outlook revenue miss pdonald trump is winning the currency cold war pimco phow to thrive at work when your boss wants you to quit pfacebook hits  billion users earnings beat live blog p‘game of thrones’ science let’s take a closer look at that greyscale p‘game of thrones’ the four biggest takeaways from stormborn’ pbreakingnutrisystem shares jump  following q earnings ptop  most annoying people you may want to unfriend on facebook pif you can buy only one stock or etf make it this one loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert new york markets after hours market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pfacebook hits  billion users earnings beat live blog pstock market ends at record on robust earnings as fed issues policy update ptrump puts his hands together for ‘the late great abraham lincoln’ pthe nintendo switch’s sellout launch in many charts pyear treasury yield falls the most in five weeks after fed statement pfor transgender americans workplace discrimination isn’t limited to the military pyour k match may have some strings attached pthis is the worst mistake people make at work pwhy equalweighted stockmarket indexes bounce back faster from bear markets pnutrisystem shares rally on betterthanexpected earnings pbuffalo wild wings drop  on high chicken wing costs pbreakingf networks shares fall after weak outlook revenue miss pdonald trump is winning the currency cold war pimco phow to thrive at work when your boss wants you to quit pfacebook hits  billion users earnings beat live blog p‘game of thrones’ science let’s take a closer look at that greyscale p‘game of thrones’ the four biggest takeaways from stormborn’ pbreakingnutrisystem shares jump  following q earnings ptop  most annoying people you may want to unfriend on facebook pif you can buy only one stock or etf make it this one loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert new york markets after hours market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pfacebook hits  billion users earnings beat live blog pstock market ends at record on robust earnings as fed issues policy update ptrump puts his hands together for ‘the late great abraham lincoln’ pthe nintendo switch’s sellout launch in many charts pyear treasury yield falls the most in five weeks after fed statement pfor transgender americans workplace discrimination isn’t limited to the military pyour k match may have some strings attached pthis is the worst mistake people make at work pwhy equalweighted stockmarket indexes bounce back faster from bear markets pnutrisystem shares rally on betterthanexpected earnings pbuffalo wild wings drop  on high chicken wing costs pbreakingf networks shares fall after weak outlook revenue miss pdonald trump is winning the currency cold war pimco phow to thrive at work when your boss wants you to quit pfacebook hits  billion users earnings beat live blog p‘game of thrones’ science let’s take a closer look at that greyscale p‘game of thrones’ the four biggest takeaways from stormborn’ pbreakingnutrisystem shares jump  following q earnings ptop  most annoying people you may want to unfriend on facebook pif you can buy only one stock or etf make it this one loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  mirn stock price  mirna therapeutics inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers ba  t  amd  biib  akam  uhs  rhi  jnpr  latest newsall times eastern p facebook hits  billion users earnings beat live blog p updated stock market ends at record on robust earnings as fed issues policy update p updated trump puts his hands together for ‘the late great abraham lincoln’ p updated the nintendo switch’s sellout launch in many charts p updated year treasury yield falls the most in five weeks after fed statement p updated for transgender americans workplace discrimination isn’t limited to the military p updated your k match may have some strings attached p this is the worst mistake people make at work p why equalweighted stockmarket indexes bounce back faster from bear markets p nutrisystem shares rally on betterthanexpected earnings to be replaced home investing quotes stocks united states mirn overview compare quotes stock screener earnings calendar sectors nasdaq mirn us nasdaq join td ameritrade find a broker mirna therapeutics inc watchlist createmirnalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee na pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones mirna therapeutics downgraded to perform from outperform at oppenheimer sep   at  am et by tomi kilgore mima therapeutics downgraded to market perform from outperform at leerink partners aug   at  am et by tomi kilgore the daily startup market turbulence puts biotech ipos in question oct   at  am et on the wall street journal recent news other news press releases medicenna bolsters management team medicenna bolsters management team jul   at  am et on cnw group applied optoelectronics inc aaoi leads  notable investor filings applied optoelectronics inc aaoi leads  notable investor filings may   at  am et on investorplacecom air products  chemicals inc apd and united security bancshares usbo lead  investor filings air products  chemicals inc apd and united security bancshares usbo lead  investor filings may   at  am et on investorplacecom mirna therapeutics to merge with synlogic mirna therapeutics to merge with synlogic may   at  am et on seeking alpha premarket gainers as of  am premarket gainers as of  am may   at  am et on seeking alpha zackscom featured highlights mannkind mirna therapeutics nextera energy sabre and avinger dec   at  am et on zackscom profit from these  stocks with rising pe ratio dec   at  am et on zackscom zackscom featured highlights mannkind mirna therapeutics nextera energy one gas and avinger dec   at  am et on zackscom buy  stocks with rising pe to bust a common myth dec   at  am et on zackscom q mirna therapeutics inc nov   at  pm et on edgar online  edg  q k healthcare ratings roundup  upgradesdowngrades sep   at  am et on seeking alpha biggest movers in manufacturing stocks now – aks mdgl kin mrtx sep   at  pm et on investorplacecom exploring grahams netnet working capital strategy part  the first  months sep   at  pm et on seeking alpha healthcare ratings roundup  new coverage sep   at  am et on seeking alpha hottest manufacturing stocks now – epzm fit dmpi crbp sep   at  pm et on investorplacecom mirna therapeutics mirn is in oversold territory whats next sep   at  am et on zackscom hottest manufacturing stocks now – spu ccur mirn mtl aug   at  am et on investorplacecom biggest movers in manufacturing stocks now – yeco kura vtgn cnce aug   at  pm et on investorplacecom value screeners identify cheap company stocks aug   at  pm et on gurufocuscom hottest manufacturing stocks now – cycc mdvn yeco bnso aug   at  pm et on investorplacecom blog coverage mirna announced reverse merger agreement blog coverage mirna announced reverse merger agreement may   at  am et on accesswire synlogic and mirna therapeutics agree to merger synlogic and mirna therapeutics agree to merger may   at  am et on businesswire  bzx mirna therapeutics reports first quarter  financial results mirna therapeutics reports first quarter  financial results may   at  pm et on businesswire  bzx mirna therapeutics reports financial results for the fourth quarter and full year ended december   mar   at  pm et on businesswire  bzx mirna therapeutics reports third quarter  financial results and mrx clinical program updates nov   at  pm et on businesswire  bzx mirna therapeutics halts phase  clinical study of mrx sep   at  pm et on businesswire  bzx mirna therapeutics to participate in two healthcare investor conferences in september aug   at  am et on businesswire  bzx mirna therapeutics reports second quarter  financial results and program updates aug   at  am et on businesswire  bzx mirna therapeutics inc mirna therapeutics inc is a biopharmaceutical company which engages in the development of micrornabased oncology therapeutics its products includes mir mir mir mir and let the company was founded matthew m winkler in  and is headquartered in austin tx see full profile analyst ratings sell under hold over buy number of ratings  full ratings mirnas murky clinical strategy leaves hc wainwright hesitant sep   at  am et on benzingacom benzingas top downgrades sep   at  am et on benzingacom hc wainwright initiates mirna at buy sees  upside sep   at  pm et on benzingacom competitors name chg  market cap petmed express inc  m nexgenrx inc  m pharmerica corp  m omni health inc  m competitor data provided by partner content trending tickers powered by fb  gild  pypl  jdst  jnug  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience mirn stock price  news  mirna therapeutics inc  wall street journal dow jones a news corp company news corp is a network of leading companies in the worlds of diversified media news education and information services dow jones barrons bigcharts djx dow jones newswires factiva financial news mansion global marketwatch newsmart newsplus private markets risk  compliance wsjcom wsj pro wsj conference wsj video news corp big decisions business spectator checkout harper collins new york post proptiger rea realtorcom storyful the australian the sun the times djia ▲     sp  ▲     nasdaq ▲     us  yr ▲  yield    crude oil ▲     euro ▲     subscribe now sign in the wall street journal us edition us asia europe india  china  japan july   todays paper sections my journal home world us politics economy business tech markets opinion arts life real estate todays paper show all sections hide all sections world home africa asia canada china europe latin america middle east economy world video us home economy law new york politics real time economics washington wire journal report us video whats news podcast politics home washington wire politics video wsjnbc news poll economy home real time economics economic forecasting survey economy video business home management techwsjd aerospace  defense autos  transportation commercial real estate consumer products energy entrepreneurship financial services food  services health care hospitality law manufacturing media  marketing natural resources retail cfo journal cio journal cmo today logistics report risk  compliance heard on the street business video journal report business podcast tech home cio journal geoffrey fowler christopher mims joanna stern li yuan billion dollar startup club tech video tech podcast startup stock trader markets home bonds commercial real estate commodities  futures currencies deals financial services funds stocks your money heard on the street moneybeat wealth adviser ahead of the tape cfo journal journal report market data markets video markets podcast moneybeat podcast watching your wealth podcast opinion home james freeman william a galston daniel henninger holman w jenkins william mcgurn peggy noonan mary anastasia ogrady jason riley kimberley a strassel books film television theater art masterpiece series music dance opera exhibition cultural commentary editorials commentary letters to the editor the weekend interview potomac watch podcast foreign edition podcast opinion video notable  quotable best of the web newsletter morning editorial report newsletter arts home books film television theater art masterpiece series arts video wsj magazine life home careers cars food  drink health ideas real estate science sports style  fashion travel life video wsj magazine wsj puzzles the future of everything real estate home commercial real estate house of the day mansion real estate video hide all sections aim higher reach further get the wall street journal  for  weeks subscribe now sign in reveal navigation options subscribe sign in mirna therapeutics inc mirn us nasdaq search view all companies at close  pm edt   usd   volume  volume   day avg vol   day range     week range        d  d  m  m ytd  y  y   advanced charting compare compare to benchmark djia sp  global dow nasdaq health carelife sciences compare to add open  prior close    day mirn  djia  russell k  health carelife sciences  overview overview profile financials income statement balance sheet cash flow research  ratings historical prices options advanced charting news mirna therapeutics incmirn significant news only  dow jones newswires mirna therapeutics files k  termination of definitive agreement dow jones newswires  dow jones newswires mirna therapeutics files k  changes exec mgmt dow jones newswires  press release mirna therapeutics reports first quarter  financial results press release load more key stock data  pe ratio ttm the price to earnings pe ratio a key valuation measure is calculated by dividing the stocks most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing  month period earnings per share ttm a companys net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding market capitalization reflects the total market value of a company market cap is calculated by multiplying the number of shares outstanding by the stocks price for companies with multiple common share classes market capitalization includes both classes shares outstanding number of shares that are currently held by investors including restricted shares owned by the companys officers and insiders as well as those held by the public public float the number of shares in the hands of public investors and available to trade to calculate start with total shares outstanding and subtract the number of restricted shares restricted stock typically is that issued to company insiders with limits on when it may be traded dividend yield a companys dividend expressed as a percentage of its current stock price key stock data pe ratio ttm na eps ttm  market cap  m shares outstanding  m public float  m yield mirn has not issued dividends in more than  year latest dividend na exdividend date na  shares sold short the total number of shares of a security that have been sold short and not yet repurchased change from last percentage change in short interest from the previous report to the most recent report exchanges report short interest twice a month percent of float total short positions relative to the number of shares available to trade short interest  shares sold short  change from last  percent of float   money flow uptickdowntick ratio money flow measures the relative buying and selling pressure on a stock based on the value of trades made on an uptick in price and the value of trades made on a downtick in price the updown ratio is calculated by dividing the value of uptick trades by the value of downtick trades net money flow is the value of uptick trades minus the value of downtick trades our calculations are based on comprehensive delayed quotes stock money flow uptickdowntick trade ratio    net money flow   money flow gives a snapshot of relative buying and selling pressure in a stock a ratio above one suggests greater buying pressure below one suggests greater selling advertisement competitors mirn company change pe ttm pets petmed express inc    nxg nexgenrx inc    pmc pharmerica corp    omhe omni health inc    more information on mirn competitor data provided by capital cube profile mirn mirna therapeutics inc is a biopharmaceutical company which engages in the development of micrornabased oncology therapeutics its products includes mir mir mir mir and let the company was founded matthew m winkler in  and is headquartered  south capital of texas highway austin texas  united states website map employees  sector biotechnology sales or revenue  industry health carelife sciences y sales change  fiscal year ends december  download reports paul lammers president chief executive officer  director alan fuhrman cfo  principal accounting officer casi deyoung chief business officer sinil kim vice presidentoncology more research  ratings mirna therapeutics incmirn pershare earnings actuals and estimates quarterly annual mirn will report fy  earnings on false mirn will report q earnings on false actual analyst range consensus       na    q q q q q q     actual      fy  fy  fy  fy  q  estimate trends current   month ago   months ago  q  estimate trends current   month ago   months ago  fy  estimate trends current   month ago   months ago  fy  estimate trends current   month ago   months ago  more financials mirna therapeutics incmirn quarterly annual net income   m m m mar  jun  sep  dec  mar    m m m m      mar  quarter trend net income growth  sales or revenue  sales or revenue growth  ebitda  m  year trend net income growth  sales or revenue  sales or revenue growth  ebitda  m more overview notes  data providers realtime us stock quotes reflect trades reported through nasdaq only international stock quotes are delayed as per exchange requirements indexes may be realtime or delayed refer to time stamps on index quote pages for information on delay times quote data except us stocks provided by six financial information data is provided as is for informational purposes only and is not intended for trading purposes six financial information a does not make any express or implied warranties of any kind regarding the data including without limitation any warranty of merchantability or fitness for a particular purpose or use and b shall not be liable for any errors incompleteness interruption or delay action taken in reliance on any data or for any damages resulting therefrom data may be intentionally delayed pursuant to supplier requirements all of the mutual fund and etf information contained in this display was supplied by lipper a thomson reuters company subject to the following copyright  thomson reuters all rights reserved any copying republication or redistribution of lipper content including by caching framing or similar means is expressly prohibited without the prior written consent of lipper lipper shall not be liable for any errors or delays in the content or for any actions taken in reliance thereon bond quotes are updated in realtime source tullett prebon currency quotes are updated in realtime source tullet prebon fundamental company data and analyst estimates provided by factset copyright factset research systems inc all rights reserved advertisement mirn key statistics  mirna therapeutics inc financial ratios  marketwatch bulletin investor alert new york markets after hours market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close mirna therapeutics inc nasdaq mirn go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus mirna therapeutics inc market closed  quotes are delayed by  min jul    pm mirn quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description mirna therapeutics inc is a biopharmaceutical company which engages in the development of micrornabased oncology therapeutics its products includes mir mir mir mir and let the company was founded matthew m winkler in  and is headquartered in austin tx valuation pe current  pe ratio with extraordinary items  price to book ratio  enterprise value to ebitda  total debt to enterprise value  efficiency income per employee  liquidity current ratio  quick ratio  cash ratio  profitability return on assets  return on equity  return on total capital  return on invested capital  capital structure total debt to total equity  total debt to total capital  total debt to total assets  longterm debt to equity  longterm debt to total capital  officers and executives name age officer since title dr paul lammers   president chief executive officer  director mr alan fuhrman   cfo  principal accounting officer ms casi deyoung   chief business officer dr sinil kim   vice presidentoncology mr jon irvin   vice presidentfinance insider actions – purchase – sale  – number of transactions  date name shares transaction value  jon irvin vice president finance    disposition at  per share   jon irvin vice president finance    disposition at  per share   jon irvin vice president finance    disposition at  per share   jon irvin vice president finance    disposition at  per share   jon irvin vice president finance    disposition at  per share   sofinnova ventures inc    acquisition at  per share   sofinnova ventures inc    acquisition at  per share   new enterprise associates llc    acquisition at  per share   new enterprise associates llc    acquisition at  per share   new enterprise associates llc    acquisition at  per share   new enterprise associates llc    acquisition at  per share   new enterprise associates llc    acquisition at  per share   new enterprise associates llc    acquisition at  per share   new enterprise associates llc    acquisition at  per share   new enterprise associates llc    acquisition at  per share   new enterprise associates llc    acquisition at  per share   new enterprise associates llc    acquisition at  per share   new enterprise associates llc    acquisition at  per share   new enterprise associates llc    acquisition at  per share   pfizer venture investments    acquisition at  per share   sofinnova ventures inc      sofinnova ventures inc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      new enterprise associates llc      pfizer venture investments      matthew m winkler director      matthew m winkler director      matthew m winkler director      matthew m winkler director      lawrence m alleva director      new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   new enterprise associates llc    derivativenonderivative trans at  per share   matthew m winkler director    derivativenonderivative trans at  per share   matthew m winkler director    derivativenonderivative trans at  per share   matthew m winkler director    derivativenonderivative trans at  per share   matthew m winkler director    derivativenonderivative trans at  per share   matthew m winkler director    derivativenonderivative trans at  per share   matthew m winkler director    derivativenonderivative trans at  per share   matthew m winkler director    derivativenonderivative trans at  per share   matthew m winkler director    derivativenonderivative trans at  per share   matthew m winkler director    derivativenonderivative trans at  per share   matthew m winkler director    derivativenonderivative trans at  per share   lawrence m alleva director    derivativenonderivative trans at  per share  newslatestcompanyusmirn marketwatch news on mirn mirna therapeutics downgraded to perform from outperform at oppenheimer  am sept    tomi kilgore mima therapeutics downgraded to market perform from outperform at leerink partners  am aug    tomi kilgore newsnonmarketwatchcompanyusmirn other news on mirn applied optoelectronics inc aaoi leads  notable investor filings  am may    investorplacecom air products  chemicals inc apd and united security bancshares usbo lead  investor filings  am may    investorplacecom mirna therapeutics to merge with synlogic  am may    seeking alpha premarket gainers as of  am  am may    seeking alpha zackscom featured highlights mannkind mirna therapeutics nextera energy sabre and avinger  am dec    zackscom profit from these  stocks with rising pe ratio  am dec    zackscom zackscom featured highlights mannkind mirna therapeutics nextera energy one gas and avinger  am dec    zackscom buy  stocks with rising pe to bust a common myth  am dec    zackscom q mirna therapeutics inc  pm nov    edgar online  edg  q k healthcare ratings roundup  upgradesdowngrades  am sept    seeking alpha biggest movers in manufacturing stocks now – aks mdgl kin mrtx  pm sept    investorplacecom exploring grahams netnet working capital strategy part  the first  months  pm sept    seeking alpha healthcare ratings roundup  new coverage  am sept    seeking alpha hottest manufacturing stocks now – epzm fit dmpi crbp  pm sept    investorplacecom mirna therapeutics mirn is in oversold territory whats next  am sept    zackscom hottest manufacturing stocks now – spu ccur mirn mtl  am aug    investorplacecom biggest movers in manufacturing stocks now – yeco kura vtgn cnce  pm aug    investorplacecom value screeners identify cheap company stocks  pm aug    gurufocuscom hottest manufacturing stocks now – cycc mdvn yeco bnso  pm aug    investorplacecom biggest movers in manufacturing stocks now – lptn reta yeco amd  am aug    investorplacecom loading more headlines at a glance mirna therapeutics inc  south capital of texas highway building  suite  austin texas  phone   industry biotechnology sector health carelife sciences fiscal yearend  view sec filings revenue na net income m employees  annual report for mirn newspressreleasecompanyusmirn press releases on mirn blog coverage mirna announced reverse merger agreement  am may    accesswire synlogic and mirna therapeutics agree to merger  am may    businesswire  bzx mirna therapeutics reports first quarter  financial results  pm may    businesswire  bzx mirna therapeutics reports financial results for the fourth quarter and full year ended december    pm march    businesswire  bzx mirna therapeutics reports third quarter  financial results and mrx clinical program updates  pm nov    businesswire  bzx mirna therapeutics halts phase  clinical study of mrx  pm sept    businesswire  bzx mirna therapeutics to participate in two healthcare investor conferences in september  am aug    businesswire  bzx mirna therapeutics reports second quarter  financial results and program updates  am aug    businesswire  bzx trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pfacebook hits  billion users earnings beat live blog pstock market ends at record on robust earnings as fed issues policy update ptrump puts his hands together for ‘the late great abraham lincoln’ pthe nintendo switch’s sellout launch in many charts pyear treasury yield falls the most in five weeks after fed statement pfor transgender americans workplace discrimination isn’t limited to the military pyour k match may have some strings attached pthis is the worst mistake people make at work pwhy equalweighted stockmarket indexes bounce back faster from bear markets pnutrisystem shares rally on betterthanexpected earnings pbuffalo wild wings drop  on high chicken wing costs pbreakingf networks shares fall after weak outlook revenue miss pdonald trump is winning the currency cold war pimco phow to thrive at work when your boss wants you to quit pfacebook hits  billion users earnings beat live blog p‘game of thrones’ science let’s take a closer look at that greyscale p‘game of thrones’ the four biggest takeaways from stormborn’ pbreakingnutrisystem shares jump  following q earnings ptop  most annoying people you may want to unfriend on facebook pif you can buy only one stock or etf make it this one loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  mirna therapeutics halts phase  clinical study of mrx  business wire mirna therapeutics halts phase  clinical study of mrx management to host conference call and webcast today at  pm eastern september    pm eastern daylight time austin texasbusiness wiremirna therapeutics inc nasdaqmirn a clinical stage biopharmaceutical company today announced its decision to close the ongoing phase  study of mrx its investigational microrna therapy for multiple cancers the company voluntarily halted enrollment and dosing in the clinical study following multiple immunerelated severe adverse events sae observed in patients dosed with mrx over the course of the trial “patient safety is the primary objective of our mrx phase  clinical trial” said president and ceo paul lammers md msc “we made the difficult decision to close the study after a fifth immunerelated serious adverse event was recently reported by one of our clinical sites this patient experienced severe grade  cytokine release syndrome and is undergoing treatment we have notified the us fda and the korean fda of our decision and are in the process of closing the trial” mirna also announced that it will not be initiating a translational medicine study of mrx in melanoma patients planned to begin later this year the company will be further analyzing its full preclinical and clinical data set and will discuss with its advisors as well as the fda possible future development of mrx and will provide updates when appropriate conference call details to access the call participants should dial  us  canada or  international at least  minutes prior to the start of the call the call will be webcast live and may be accessed from the events  presentations section of the companys website an archived version of the webcast will be available for replay following the event about mirna therapeutics inc mirna is a clinical stage biopharmaceutical company developing micrornabased oncology therapeutics and is the first to bring a synthetic microrna mimic into clinical development for the treatment of cancer mirnas lead product candidate mrx a mimic of naturally occurring microrna mir has been studied in a phase  clinical trial which included patients with primary liver cancer advanced solid tumors and hematological malignancies mir is one of the most widely published micrornas and is considered a key regulator of multiple oncogenes across key oncogenic pathways with the capacity to regulate more than  different oncogenes and repress immune checkpoint signaling molecules including pdl the company was founded in  and is located in austin texas for more information visit wwwmirnarxcom forwardlooking statements to the extent that statements contained in this press release are not descriptions of historical facts regarding mirna they are forwardlooking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the private securities litigation reform act of  including statements regarding possible future mrx development such forwardlooking statements involve substantial risks and uncertainties that could cause our clinical development program future results performance or achievements to differ significantly from those expressed or implied by the forwardlooking statements such risks and uncertainties include among others the uncertainties inherent in the clinical drug development process including the outcomes of clinical trials the regulatory approval process our substantial dependence on mrx our commercialization plans and efforts and other matters that could affect the availability or commercial potential of our product candidates and the risk that our product candidates may cause undesirable side effects or have other properties that could delay or prevent their regulatory approval we undertake no obligation to update or revise any forwardlooking statements for a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forwardlooking statements as well as risks relating to our business in general see our annual report on form k filed with the us securities and exchange commission sec on march   and our quarterly report on form q filed with the sec on august   contacts investorsthe trout grouppete rahmer prahmertroutgroupcomormediabmc communicationsamy bonanno abonannobmccommunicationscom contacts investorsthe trout grouppete rahmer prahmertroutgroupcomormediabmc communicationsamy bonanno abonannobmccommunicationscom search advanced news search advanced news search log in sign up microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft microrna analysis using taqman assays  thermo fisher scientific search go contact us account sign in quick order sign in register account orders favorites shared lists custom products  projects instrument management manage instrument use information and service profile popularpopular  taqman realtime pcr assays  antibodies  oligos primers  probes  geneart gene synthesis  cell culture plasticsapplications  techniquessee links for applications  techniquesbrandssee links for brandsthermo scientificapplied biosystemsinvitrogengibcoion torrentlife sciencessee links for life sciencesantibodiescell analysiscell culture  transfectioncloningdna  rna purification  analysisepigeneticsflow cytometrygene expression analysis  genotypinggenome editingmicroarray analysispcrprotein biologyrealtime pcrrnaisequencingstem cell researchsynthetic biologyindustrial  applied sciencesee links for industrial  applied scienceagricultural biotechnologyanimal healthbioproductioncement coal  mineralschromatographydrug discovery  developmentenvironmentalfood  beverageforensicsmanufacturing  processingmass spectrometrymicrobiologypharma  biopharmaradiation detection  measurementspectroscopy elemental  isotope analysisclinical  diagnosticssee links for clinical  diagnosticsanatomical pathologybiobankingcancer researchclinical microbiologyclinical  translational researchdiagnostic developmentdiagnostic testingpreclinical to companion diagnostic developmentpublic healthlab solutionssee links for lab solutionschemicalslab automationlab data management  analysis softwarelab equipmentlab plasticware  suppliesother resourcesproduct selection guidesservicesnew productspromotionsonline offerslearning centersoem  commercial supplyshop all productssee links for shop all products           most popular productsbeakerslab centrifugesultra low–temperature freezerslipofectamine reagentsnalgene labwareoligos primers probes  nucleotidespipettes  pipette tipssuperscript reverse transcriptasetaqman realtime pcr assaystrizol reagentsmost popular categoriesantibodies  immunoassayscell culture  transfection reagentschromatography columns resins  spin filtersdrug discovery assaysgels  membranesinstruments  equipmentlab reagents  chemicalslab supplies plastics  glasswareprimersoligos cloning  gene synthesissoftware  digital storageorder toolshow to orderquick ordertrack your orderorder historyorder supportcontact usshop all productssee links for shop all productsshop all servicesproduct selection guidesservices  supportsee links for services  supportmanuals  protocolsmanualssupplemental protocolscertificatescertificates of analysis and conformancedeclarations of conformitymanufacturing site iso certificationsrohs certificatesproduct informationsdssvector mapschemical structuresspectral datamedia formulationspublicationscitations  referencesnewsletters  journalsproduct literatureservicescustom servicesenterpriselevel lab informaticsenterprise servicesfinancial and leasing servicesinstrument servicesoem  commercial supplytraining  educationeventshow to  educational videoslearning centerstraining serviceswebinarsproduct supportinstrument supportknowledge baseproduct faqslife sciences support centerscontact ustools  calculatorsantibody searchbiotinylation reagent selection toolcell staining toolcrosslinker selection toolelisa kits by target toolfluorescence spectraviewerlab appsrestriction enzyme finderspectra datathermo scientific molecular biology toolsvector selection toolabout ussee links for about useventscareersinvestorsnewsresponsibilitypartnering cloud home › life sciences › pcr › realtime pcr qpcr › realtime pcr assays › microrna analysis using taqman assays microrna analysis using taqman assays see navigation ‹ realtime pcr assays gene expression analysis using taqman assays › microrna analysis using taqman assays single tube taqman microrna assays single tube taqman primirna assays single tube taqman noncoding rna assays single tube custom taqman® small rna assays taqman microrna profiling using well array cards taqman microrna profiling using the quantstudio k flex realtime pcr system with openarray block which taqman microrna or noncoding rna assayarray product is right for you taqman mirna abc purification kit educational resources for taqman® microrna assays taqman advanced mirna assays snp genotyping analysis using taqman assays › drug metabolism genotyping analysis using taqman assays › mutation detection analysis using taqman assays › copy number variation analysis using taqman assays › taqman flexible content panels › common taqman myths busted › why choose taqman assays › taqman custom assay manufacturing  plating services › taqman service providers › applied biosystems™ taqman™ microrna assays are innovative tools for mirna research—from isolation through discovery profiling quantitation validation and functional analysis there are now even more choices for detection of mature biologically active mirna designed to support a growing range of mirna applications the new applied biosystems™ taqman advanced mirna assays use ligationbased universal reverse transcription for a streamlined and highly sensitive workflow the standard taqman microrna assays which employ targetspecific stemloop reverse transcription primers for ’ extended templates continue to cover a range of species using standard taqman assay–based realtime pcr taqman advanced mirna assays on cards and plates be one of the first to use our taqman advanced mirna chemistry on a taqman array card or openarray plate enable highly sensitive and specific quantification of mirnas in a high throughput format request early access new taqman advanced mirna assays new taqman advanced mirna assays use universal reverse transcription and provide highly sensitive quantification taqman microrna assays standard taqman microrna assays use a targetspecific stemloop reverse transcription primer taqman primirna assays applied biosystems™ taqman™ primirna assays detect and measure primary mirnas from human mouse or rat species assay search tool  find  buy your single tube taqman assays src wwwthermofishercom order genomedatabase assets core img loadergif  mirbase v update the content for our standard taqman microrna assays and the new taqman advanced mirna assays is aligned with release  of the mirbase database for a complete list of standard taqman microrna assays taqman advanced mirna assays and other technical resources please visit our taqman microrna assays resource page additional mirna assays by type taqman noncoding rna assays applied biosystems™ taqman™ noncoding rna assays for reliable detection and quantitation of noncoding human mouse or rat transcripts longer than  nucleotides custom taqman small rna assays custom assays to quantitate small rna are ideal to quantitate your small rna when a predesigned assay is unavailable—all you need is the sequence of interest mirna assays by format well plates order your taqman microrna assays preplated into fast or standard well plates with the applied biosystems™ taqman™ custom plating service perfect for analyzing a large number of samples for a few target mirnas or noncoding rnas or the converse evaluating a few samples for a large number of targets well microfluidic cards well cards are ideal for profiling studies across a small number of samples up to  samples per card or with limited sample material each reaction requires only  µl of sample and are compatible with applied biosystems™ viia™  and ht realtime pcr systems well plates order your taqman microrna assays preplated into fast or standard well plates with the taqman custom plating service perfect for analyzing a large number of samples for a few target mirnas or noncoding rnas or the converse evaluating a few samples for a large number of targets openarray plates these plates accommodate  reactions at once delivering the highthroughput capabilities required for large profiling studies designed for use with the applied biosystems™ openarray™ realtime pcr system and the new applied biosystems™ quantstudio™ k flex realtime pcr system   video find the right taqman microrna assayits never been easier to search over  taqman microrna assays with the new assay search tool from thermo fisher scientific watch this short video to see how easy it is to find the right taqman microrna assay resources download your taqman documentation files which taqman microrna or noncoding rna assay is right for you microrna and noncoding rna applications for qpcr taqman microrna assays faqs product bulletin quantitate micrornas with the specificity and sensitivity of realtime pcr download complete list of taqman microrna assays new protocol for generating custom pools of rt primers brochure taqman microrna assays support get the latest news from behind the bench blog local taqman service providers software for microrna and noncoding rna analysis realtime pcr instrument support center realtime pcr applications support center realtime pcr education center for research use only not for use in diagnostic procedures             brands shopping tool product selection guides quick order redeem a quote go  please enter a valid quote new products promotions mobile  desktop apps shared lists esolutions eprocurement supply center instrument management support order support training webinars blog social media contact us report a site issue thermo fisher scientific about us careers investors news responsibility trademarks terms  conditions privacy policy price  freight policy   note you clicked on an external link which has been disabled in order to keep your shopping session open ok view highvolume categories by popularity our choices favorites category title view top sellers by popularity favorites price brand title view categories by popularity our choices favorites category title primary antibodies secondary antibodies isotype controls view products by popularity favorites price brand title welcome to mirna therapeutics about us clinical trials  pipeline technology investor relations careers contact us about mirna   mirna is a biopharmaceutical company focused on micrornabased oncology therapeutics   learn more about us   clinical trials   mrx mirna’s first product candidate was the first microrna mimic to enter clinical testing latest news   may   synlogic and mirna therapeutics agree to merger   may   mirna therapeutics reports first quarter  financial results   view all news   contact    sitemap   mirna therapeutics inc all rights reserved bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one